CONFERENCE COMMITTEE REPORT NO. 46

                            Honolulu, Hawaii
                                            , 1999

                            RE:   S.B. No. 1018
                                  S.D. 1
                                  H.D. 2
                                  C.D. 1




Honorable Norman Mizuguchi
President of the Senate
Twentieth State Legislature
Regular Session of 1999
State of Hawaii

Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twentieth State Legislature
Regular Session of 1999
State of Hawaii

Sir:

     Your Committee on Conference on the disagreeing vote of the
Senate to the amendments proposed by the House of Representatives
in S.B. No. 1018, S.D. 1, H.D. 2, entitled:  

     "A BILL FOR AN ACT RELATING TO THE DRUG FORMULARY," 

having met, and after full and free discussion, has agreed to
recommend and does recommend to the respective Houses the final
passage of this bill in an amended form.

     The purpose of this measure is to allow the Drug Product
Selection Board (Board) to adopt as rules the "Approved Drug
Products with Therapeutic Equivalence Evaluations", known as the
Orange Book, as a state drug formulary, including a Hawaii
additions and deletions list.

     Upon further consideration, your Committee on Conference has
amended this measure by:

     (1)  Providing that the Board may adopt administrative rules
          to establish a Hawaii additions and deletions list;


 
a                                                     SB1018 CD1
                                                      
                            CONFERENCE COMMITTEE REPORT NO. 46
                            Page 2



     (2)  Deleting reference to the Board meeting no less than
          every six months;

     (3)  Clarifying that an anti-epileptic drug for the
          treatment of epilepsy shall not be substituted; and

     (4)  Making a nonsubstantive amendment for proper drafting
          style.

     Your Committee on Conference is in accord with the intent
and purpose of S.B. No. 1018, S.D. 1, H.D. 2, as amended herein,
and recommends that it pass Final Reading in the form attached
hereto as S.B. No. 1018, S.D. 1, H.D. 2, C.D. 1.

                                   Respectfully submitted,

MANAGERS ON THE PART OF THE        MANAGERS ON THE PART OF THE
            HOUSE                             SENATE
                                   
                                   
                                   
______________________________     ______________________________
MARILYN B. LEE, Co-Chair           SUZANNE CHUN OAKLAND, Chair
                                   
                                   
                                   
______________________________     ______________________________
BRIAN Y. YAMANE, Co-Chair          RANDY IWASE, Member
                                   
                                   
                                   
______________________________     ______________________________
LEI AHU ISA, Member                WHITNEY ANDERSON, Member



______________________________
NESTOR R. GARCIA, Member



______________________________
GALEN FOX, Member


 
a                                                     SB1018 CD1